Why Healthtech Founders Face This Challenge
Most AI development agencies have no meaningful experience with the regulatory requirements of UK clinical AI products. They understand GDPR in a general sense, but they do not understand the specific requirements of special category health data processing under UK GDPR and the Data Protection Act 2018. They have not designed systems with DTAC assessment criteria in mind. They do not know what NHS Digital's Data Security and Protection Toolkit requires in terms of information governance, and they have not thought through what MHRA expects from a Software as a Medical Device product seeking regulatory approval. The result is that many healthtech founders have had the experience of commissioning an AI product, receiving something technically capable, and then discovering that it cannot proceed to NHS procurement or clinical pilot because the data handling approach is non-compliant, the audit trail is insufficient for clinician trust, or the regulatory classification of the software has not been addressed. Rebuilding a system to meet these requirements is typically more expensive than building it right the first time. The clinical trust problem is a separate challenge. AI outputs in a clinical context are not evaluated on the same basis as AI outputs in a consumer context. Clinicians need to understand why a recommendation was made, what data it was based on, what the limitations of the underlying model are, and what the failure modes look like. An AI system that produces accurate outputs without explainability is not usable in clinical practice. The liability exposure if a clinician acts on an unexplained AI output that turns out to be wrong is not a commercial risk. It is a patient safety risk.
What Healthtech Founders Actually Need from an AI Development Partner
Your goals as a healthtech founder are shaped by a regulatory and clinical context that is unlike any other vertical. You need to build a clinically validated AI MVP that can survive NHS procurement and DTAC assessment. DTAC is the Digital Technology Assessment Criteria framework that NHS organisations use to evaluate digital health tools, and it covers clinical safety, data protection, technical security, interoperability, and usability. A product that does not meet these criteria cannot progress through NHS procurement regardless of its clinical merit. You need to demonstrate safe, explainable AI outputs that clinicians can trust and document. Explainability in a clinical AI context means the system can describe why it produced a given output, what data it relied on, what its confidence is, and what the known limitations of the underlying model are. Clinicians need to be able to document their use of an AI tool in clinical records, which requires that they understand what the tool did and why. You need to achieve GDPR and NHS data security compliance before approaching NHS trusts. Special category health data under UK GDPR requires explicit lawful basis, appropriate technical and organisational measures, and in many cases formal Data Protection Impact Assessment documentation. The NHS Data Security and Protection Toolkit sets specific standards for organisations handling NHS data. Building these requirements in from the start is dramatically less expensive than retrofitting them to a non-compliant system.
How SpeedMVPs Works with Healthtech Founders
Every healthtech engagement begins with a regulatory classification conversation. Before any design work, we need to understand whether the product meets the definition of a medical device under the Medical Devices Regulations 2002 as amended, whether it falls within MHRA's guidance on Software as a Medical Device, and what clinical risk classification the system should carry under DCB0129 clinical safety standards. This classification determines the regulatory pathway and the technical requirements that the system must meet. Data handling for health data is designed at a different level of rigour than data handling for general personal data. Special category health data under UK GDPR requires explicit processing conditions, enhanced security measures, data minimisation that goes beyond the general principle, and specific retention and deletion controls. We document the lawful basis for every data processing activity and produce the Data Protection Impact Assessment documentation that the ICO requires for high-risk processing. DTAC assessment criteria are incorporated into the product design from day one: clinical safety documentation following DCB0129 standards, data protection impact assessment, Cyber Essentials Plus readiness or equivalent security posture, accessibility compliance, and interoperability with NHS systems where relevant including HL7 FHIR standards. NHS Digital's Data Security and Protection Toolkit requirements are addressed at the infrastructure and process level. Explainability for clinical AI is a technical design decision, not a post-hoc explanation layer. We build AI systems that produce outputs with accompanying rationale, confidence indicators, and limitation disclosures that meet the documentation requirements of clinical practice.
Typical Projects We Deliver for Healthtech Founders
AI MVP development for clinical contexts is the most common engagement: a first version of an AI-powered health product built with clinical safety, regulatory compliance, and NHS procurement readiness as primary design requirements alongside the clinical capability itself. This includes the clinical safety case documentation alongside the technical build. AI consulting and compliance work is often the right starting point for healthtech founders who need an independent assessment of their regulatory position before committing to a build: MHRA classification assessment, DTAC gap analysis, GDPR health data compliance review, and a clear roadmap to a compliant product. AI agents and copilots for clinical contexts are increasingly relevant: AI systems that assist clinicians with specific tasks such as documentation, coding, triage support, or pathway navigation, built with the appropriate clinical safety standards, explainability requirements, and human oversight mechanisms. AI integration into existing clinical systems, including EPR systems, diagnostic equipment, or care coordination platforms, requires specific expertise in clinical data standards such as HL7 FHIR and SNOMED CT that most general AI development teams do not have. Web SaaS development for health products covers the full application layer when the AI capability needs to be delivered through a consumer-facing or clinician-facing web product with appropriate identity verification, consent management, and accessibility compliance. All deliverables include the regulatory documentation alongside the working system.
Common Mistakes Healthtech Founders Make When Hiring AI Teams
The most serious mistake is hiring a general AI development agency without verifying that they have specific experience with clinical AI regulatory requirements. GDPR experience is not the same as DTAC experience. Software development experience is not the same as Software as a Medical Device experience. Ask specifically whether the team has built products that have passed DTAC assessment, and ask to speak to founders who went through that process with them. The second mistake is treating clinical safety as a documentation exercise rather than a design requirement. Clinical safety standards under DCB0129 are not a set of forms to fill in after the product is built. They require that clinical risk is identified, assessed, and mitigated at the design stage. A product built without clinical safety consideration cannot be made compliant retroactively without significant redesign. The third mistake is under-specifying the explainability requirements. If a clinician cannot understand why an AI system produced a specific output, they cannot responsibly act on it or document their clinical decision-making. This is not a preference. It is a clinical governance requirement. Build explainability into the AI design from day one rather than attempting to add it to a black-box model output at the end. The fourth mistake is not addressing NHS Digital's Data Security and Protection Toolkit requirements before approaching NHS trusts. NHS procurement invariably requires evidence of DSP Toolkit compliance for any product handling NHS data, and demonstrating compliance takes time. Start this process early. The fifth mistake is not involving a clinical safety officer at the design stage. DCB0129 requires that a clinical safety officer takes responsibility for the clinical risk management process. Identifying and engaging this person before the build begins is part of responsible clinical product development.
Getting Started: What to Prepare Before Your Consultation
Before your consultation with SpeedMVPs, prepare a clear description of the clinical problem the AI is addressing and who the intended users are: clinicians, patients, or both. Be specific about the clinical context: primary care, secondary care, a specific specialty, or a community setting. Describe what data the system would use: patient-identifiable data, pseudonymised clinical data, or anonymised population-level data. The regulatory and data handling requirements differ significantly depending on this distinction. Note whether you believe the product meets the definition of a Software as a Medical Device, and if so, what clinical risk class you think it falls into under the Medical Devices Regulations and MHRA guidance. If you are uncertain, we can work through this together during the consultation. Note any NHS trust or integrated care board relationships you already have, as procurement requirements vary and early engagement with potential NHS customers shapes the product requirements. Consider whether you have engaged a clinical safety officer as required by DCB0129, and whether you have identified a Caldicott Guardian or equivalent information governance lead for the data processing you plan to undertake. Think about your route to validation: will you be seeking clinical evidence through a prospective study, a retrospective audit, or a controlled clinical pilot? The validation approach affects the data requirements and the ethical approval process. MHRA Software as a Medical Device guidance, DTAC assessment criteria, GDPR special category data requirements, and NHS Data Security and Protection Toolkit standards are all directly relevant to the architecture of your product. Bring your questions about any of these to the consultation. Get a free consultation at speedmvps.co.uk